A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Clinical trial NCT04144023 · RECRUITING

Trial details

NCT number: NCT04144023
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Ductal Carcinoma In Situ

Start date: 2019-06-27
Primary completion: 2027-12-31
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.